Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:735868.
doi: 10.1155/2015/735868. Epub 2015 Jun 15.

Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature

Affiliations

Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature

Yosra Cherif et al. Case Rep Endocrinol. 2015.

Abstract

Various endocrine manifestations are commonly described in myotonic dystrophy (MD), including primary hypogonadism, diabetes mellitus, and thyroid and parathyroid dysfunction. We describe a 46-year-old woman with a family history of MD with her son. She was diagnosed with cardiac arrhythmia and required the implantation of a pacemaker. She was noted to have a bilateral cataract. She complained of muscle weakness, diffuse myalgia, and palpitation. The electromyography (EMG) showed myotonic discharges. Laboratory tests showed high serum calcium 2.83 mmol/L, serum phosphate 1.2 mmol/L, parathormone 362.5 pg/mL, thyroid stimulating hormone TSH 0.02 mIU/L (normal range: 0.34-5.6 mIU/L), FT4 21.17 ng/mL, and negative anti-thyroperoxidase antibodies. Cervical ultrasound revealed a multinodular goiter. The 99mTc-MIBI scintigraphy localized a lower right parathyroid adenoma. The clinical data, the family history of MD, EMG data, and endocrine disturbances were strongly suggestive of MD associated with hyperthyroidism and primary hyperparathyroidism.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ørngreen M. C., Arlien-Søborg P., Duno M., Hertz J. M., Vissing J. Endocrine function in 97 patients with myotonic dystrophy type 1. Journal of Neurology. 2012;259(5):912–920. doi: 10.1007/s00415-011-6277-5. - DOI - PubMed
    1. Molina M. J., Lara J. I., Riobo P., et al. Primary hyperthyroidism and associated hyperparathyroidism in a patient with myotonic dystrophy: steinert with hyperthyroidism and hyperparathyroidism. The American Journal of the Medical Sciences. 1996;311(6):296–298. - PubMed
    1. Rosenberg N. L., Diliberti J. H., Andrews A. M., Buist N. R. Myotonic dystrophy and hyperparathyroidism: association with neurofibromatosis and multiple endocrine adenomatosis type 2A. Journal of Neurology, Neurosurgery & Psychiatry. 1988;51(12):1578–1580. - PMC - PubMed
    1. Steinbeck K. S., Carter J. N. Thyroid abnormalities in patients with myotonic dystrophy. Clinical Endocrinology. 1982;17(5):449–456. doi: 10.1111/j.1365-2265.1982.tb01612.x. - DOI - PubMed
    1. Fukazawa H., Sakurada T., Yoshida K., et al. Thyroid function in patients with myotonic dystrophy. Clinical Endocrinology. 1990;32(4):485–490. - PubMed

LinkOut - more resources